1. Home
  2. CBK vs ABSI Comparison

CBK vs ABSI Comparison

Compare CBK & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBK

Commercial Bancgroup Inc.

N/A

Current Price

$27.00

Market Cap

309.9M

Sector

Finance

ML Signal

N/A

Logo Absci Corporation

ABSI

Absci Corporation

HOLD

Current Price

$2.92

Market Cap

357.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBK
ABSI
Founded
1975
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
309.9M
357.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CBK
ABSI
Price
$27.00
$2.92
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.47
AVG Volume (30 Days)
42.0K
4.0M
Earning Date
04-27-2026
05-12-2026
Dividend Yield
1.49%
N/A
EPS Growth
N/A
10.64
EPS
N/A
N/A
Revenue
N/A
$4,534,000.00
Revenue This Year
$11.67
$631.04
Revenue Next Year
$8.05
$75.73
P/E Ratio
$9.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.24
$2.24
52 Week High
$27.83
$5.23

Technical Indicators

Market Signals
Indicator
CBK
ABSI
Relative Strength Index (RSI) 69.45 52.07
Support Level $23.90 $2.45
Resistance Level N/A $3.26
Average True Range (ATR) 0.83 0.23
MACD 0.24 0.02
Stochastic Oscillator 98.41 36.52

Price Performance

Historical Comparison
CBK
ABSI

About CBK Commercial Bancgroup Inc.

Commercial Bancgroup Inc a bank holding company. Through its subsidiary it is a full-service community banking institution that offers traditional consumer and commercial products and services to serve businesses and individuals in select markets in Kentucky, North Carolina, and Tennessee. Its service areas in Tennessee are (i) the Nashville MSA, (ii) the Knoxville MSA, and (iii) the Tri-Cities MSA, and (iv) Claiborne County, Cocke County, Union County, and Hamblen County, and their surrounding areas.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: